# Tariffs
Latest news and articles about Tariffs
Total: 10 articles found
Fuyao’s Glass Half Empty: Why China’s Manufacturing Icon is Threatening a US Exit
Cao Dewang, the founder of Fuyao Glass, has threatened to close his U.S. factories in response to escalating tariffs and the exclusion of Chinese EV makers from the American market. Despite record profits in the U.S., Cao's shift from an advocate for American manufacturing to a vocal critic reflects the growing geopolitical friction and the alignment of Chinese private industry with Beijing's state interests.
Transatlantic Tensions: Trump Weaponizes Tariffs in Escalating Row Over UK Digital Tax
Donald Trump has threatened the UK with significant trade tariffs unless London repeals its 2% Digital Services Tax, which primarily affects American tech giants. The UK government remains firm, stating the tax will persist until a broader international tax framework is finalized under global agreements.
A $166 Billion Retraction: US Courts Dismantle the 'Trade-by-Decree' Era
The U.S. government will return $166 billion in tariffs to importers following a Supreme Court ruling that found the use of emergency powers for trade duties was illegal. A new automated system will streamline these massive payouts, which affect over 300,000 businesses nationwide.
The 50% Ultimatum: Trump Weaponizes Trade to Sever Iran’s Military Supply Lines
President Trump has announced an immediate 50% tariff on all imports from any country that provides military weapons to Iran. The policy allows for no exemptions, marking a dramatic shift toward using total trade leverage to achieve national security goals.
The 100% Bluff: Why Washington’s Radical Drug Tariff May Never Be Collected
The U.S. government’s announcement of a 100% tariff on imported drugs is essentially a tactical negotiation tool rather than a fiscal reality. Through a series of 'Most Favored Nation' deals and manufacturing incentives, the administration is using the threat of high tariffs to force global drugmakers into domestic investment and lower pricing.
A Bitter Pill: Trump’s 100% Drug Tariffs and the Future of Chinese Biotech
President Trump has signed an executive order under Section 232 to impose 100% tariffs on imported patent drugs and APIs, aimed at forcing price concessions and manufacturing onshoring. While Chinese biotech firms face new challenges, many are already pivoting toward U.S.-based production to mitigate these trade risks.
Cracks in the Citadel: One Year After Trump’s ‘Liberation Day,’ the Cost of Isolationism Mounts
One year after the 'Liberation Day' tariff overhaul, the Trump administration has introduced 100% tariffs on pharmaceuticals and unified 25% levies on metal derivatives. These aggressive moves have accelerated a global shift away from U.S. assets and imposed multi-billion dollar costs on domestic automakers, failing to resolve underlying fiscal deficits.
Trump’s Tariff Sleight of Hand: A Nominal Cut, a Real-World Hike
The Trump administration plans to overhaul steel and aluminum tariffs by applying a 25% rate to the total value of finished goods rather than a 50% rate on their metal content. While the nominal rate is lower, the shift to a broader valuation base is expected to increase the total tax burden on importers and simplify compliance.
Tariff Recalibration: The Trump Administration’s Tactical Pivot on Metal Levies
The Trump administration plans to reduce tariffs on steel and aluminum derivatives from 50% to 25% to simplify trade rules and lower costs for businesses. This tactical shift comes ahead of the 2026 midterms as the White House balances its protectionist agenda with the need to address rising consumer prices.
Trump’s Retreat on Tariffs Leaves Greenland Dispute Unresolved and Europe Uneasy
President Trump withdrew planned tariffs on eight European countries after saying he and Western partners had sketched a framework on Greenland that covers defence and mining. European leaders welcomed the de‑escalation but remain alarmed: the episode raises fundamental questions about Greenlandic sovereignty, NATO’s role, and the resilience of the transatlantic alliance.